hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Search Results

Your search returned 438 results. You are on page 5 of 44.

Article
16 November 2015
+ Français - Hide

Author: 20 Minutes

« Pneumonie: Médecins sans frontières exige une baisse du prix du vaccin », 13 novembre 2015...

Read more

Article
22 September 2015
+ Español - Hide

Author: ForumLibertas.com

 “Standard & Poor's lanza su Índice 500 de Valores Católicos”, 21 de Septiembre de 2015...

Read more

Article
11 May 2015

The new U.S. office politics: funding your boss's political causes

Author: Michelle Conlin & Lucas Iberico Lozada, Reuters (UK)

...[E]mployers are increasingly approaching workers to fundraise, lobby and campaign in ways they never have before, according to a Reuters analysis of FEC filings and data compiled by the Business Industry Political Action Committee... [Since] a 2010...

Read more

Report
9 April 2015

Improving maternal health and access to contraceptives: Pharmaceutical companies’ contribution to MDG 5

Author: Access to Medicine Foundation

Pharmaceutical companies operationalise commitments to MDG 5 with a variety of initiatives. Ten of the world’s largest pharmaceutical companies are taking some action to improve access to maternal health and family planning, by making public...

Read more

Story
11 February 2015

Pfizer announces decision to lower price of pneumococcal vaccine by 20% but critics call reduction "meager"

See full story

Article
3 February 2015

Pfizer to further reduce Prevenar 13 price in poorest nations

Author: Axonn News Agency

Pfizer has announced that it will be taking new steps to make its Prevenar 13 vaccine accessible to people in poor countries through a new agreement with the Gavi Alliance. The company has committed to a 20 cent reduction of its per-dose price for the...

Read more

Article
27 January 2015

Pfizer Discount for its Pneumococcal Vaccine is Criticized as ‘Meager’

Author: Ed Silverman, Wall Street Journal

File this under ‘just not good enough.’ One week after being slammed over the price that poor countries pay for its pneumococcal vaccine, Pfizer PFE +3.27% announced a 6% reduction. This would bring the cost of its Prevenar 13 vaccine down 20 cents,...

Read more

Article
19 January 2015

GlaxoSmithKline & Pfizer must lower prices to make vaccines needed by children affordable in poorer countries, says MSF

Author: Sarah Boseley, Guardian (UK)

...

Read more

Article
22 December 2014

Corporate Legal Accountability Quarterly Bulletin - Issue 15, December 2014

Author: Business and Human Rights Resource Centre

Welcome to our redesigned Corporate Legal Accountability Quarterly Bulletin, streamlined to highlight a noteworthy issue each quarter, as well as key developments.  The Corporate Legal Accountability hub on our website provides objective, concise...

Read more

Article
16 December 2014
+ Français - Hide